We Are JPEO

The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) manages our nation’s investments in chemical, biological, radiological, and nuclear (CBRN) defense equipment and medical countermeasures.

The JPEO-CBRND leads, manages, and directs the acquisition, fielding and sustainment of CBRN sensors, protective equipment, medical countermeasures, specialized equipment for U.S. Special Forces, integration and information management systems, and defense enabling biotechnologies. The organization also works closely with various government agencies that need CBRN defense equipment. The JPEO-CBRND is one of the Chemical and Biological Defense Program’s four components. The Deputy Assistant Secretary of Defense for Chemical and Biological Defense oversees this program. The Assistant Secretary of the Army for Acquisition, Logistics, and Technology (ASA(ALT)), who is the Army Acquisition Executive, delegates JPEO-CBRND’s acquisition authority.

Learn more about the Joint Project Management Offices for CBRN Protection, CBRN Medical, CBRN Sensors, and CBRN SOF, and the Joint Project Lead Offices for CBRND Enabling Biotechnologies and CBRN Integration.

Learn more about the JPEO-CBRND

Our Mission

Provide integrated layered chemical, biological, radiological, and nuclear defense capabilities to the Joint Force across Combined Joint All-Domain Operations

Our Vision

A resilient Joint Force enabled to fight and win unencumbered by a chemical, biological, radiological, or nuclear environment; championed by innovative, agile, results-oriented acquisition professionals

Partnering Benefits

 

Work with the JPEO-CBRND on providing solutions that protect the Joint Force and the Warfighter from weapons of mass destruction. Help us achieve our vision of a resilient Joint Force that's enabled to fight and win unencumbered by CBRN environments.

Innovative Contracting Experience iconInnovative Contracting Experience

Our Other Transactional Authority (OTA) agreements enable enhanced communications and support innovation. 

Agile Execution iconAgile Execution

We face a complex threat environment, so we need the partnership and support of industry and academia to help us innovate at the speed of relevancy for our current CBRN defense environments.

Share iconShare Your Latest Insights with Government

The JPEO-CBRND is eager to learn more about the latest innovations, capabilities and insights to help support the Joint Force and protect our Warfighters. 

Keep Current iconKeep Current on the CBRND Industrial Base’s Needs

Gain insight into the way ahead for our organization as well as our CBRND partners.

Modernize iconHelp Modernize the Joint Force 

Help establish and refine the long-term vision for CBRND capabilities.

Speed iconDevelopment at the Speed of Relevancy

Help the JPEO-CBRND tackle the R&D needs on the horizon and learn more about our “new start” programs here.

Events

2022 Aberdeen Proving Ground (APG) Advanced Planning Briefing to Industry (APBI)
April 26-28, Aberdeen Proving Ground (Virtual), Maryland

📁 Download the slides

Featured Technologies

Joint Service General Purpose Mask (JSGPM)

Joint Service General Purpose Mask (JSGPM)

LEARN MORE

Next Generation Diagnostics System 1 (NGDS 1)

Next Generation Diagnostics System 1 (NGDS 1)

LEARN MORE

Nuclear, Biological, Chemical Reconnaissance Vehicle

Nuclear, Biological, Chemical Reconnaissance Vehicle (NBCRV)

LEARN MORE

News

Crystal Tyler, pharmacy technician, prepares an injection for an Operation Warp Speed patient volunteer at Brooke Army Medical Center, Fort Sam Houston, Texas, November 16, 2020. BAMC and Wilford Hall Ambulatory Surgical Center are participating in the Phase III trial to evaluate the vaccine under development by AstraZeneca as part of a national initiative to accelerate the development, production and distribution of COVID-19 vaccines, therapeutics and diagnostics.

DoD Awards $1.74 Billion Agreement to Moderna, Inc. to Secure Over 65 Million Doses of COVID-19 Vaccine for Fall Vaccinations

News
Jul. 29, 2022

On July 28, 2022, the Department of Defense (DoD), on behalf of and in coordination with the U.S. Department...
Read More
JPEO Enterprise Technology Tool

JETT Takes Off, Now Servicing Industry with JPMs, JPLs

News
Jul. 19, 2022

Today, the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense...
Read More
A servicemember sits in a yellow shirt in front of a table of red and blue testing vials. Covi

Biden-Harris Administration secures 3.2 million doses of Novavax COVID-19 Vaccine

News
Jul. 11, 2022

Latest vaccine will provide an additional option for the American public, pending FDA Emergency Use...
Read More
In the foreground a hand holding an orange sticker that says "I got my vaccine". In the background there are three medical personnel wearing personal protective equipment.

Biden-Harris Administration Secures More Than 100 Million Doses of Pfizer's Latest COVID-19 Vaccine for Fall Vaccine Campaign

News
Jun. 29, 2022

The U.S. Department of Health and Human Services (HHS), in collaboration with the Department of Defense (DOD),...
Read More
Two uniformed service members are in a tent. One wears PPE and a faceshield, while they use a nasal swab to collect a COVID-19 sample from the other Service member in uniform.

DOD Awards $79.9 Million Contract to Premix, Inc. to Onshore Production Capacity of Resin for Pipette Tips Required for COVID-19 Diagnostic Testing

News
May. 11, 2022

On May 5, 2022, the Department of Defense (DOD), on behalf of and in coordination with the U.S. Department of...
Read More
While wearing MOPP Level 4 gear a test player prepares to use a ROCS auto-injector on a simulated causality.

DOD-Supported 10mg Naloxone Autoinjector Receives FDA Approval to Treat Known or Potential Ultra-Potent Opioid Exposure

News
Mar. 17, 2022

On February 28, 2022, the FDA approved a 10mg naloxone autoinjector designed for non-medically trained users...
Read More
The appearance of hyperlinks does not constitute endorsement by the JPEO-CBRND of non-U.S. Government sites or the information, products, or services contained therein. Although the JPEO-CBRND may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such hyperlinks are provided consistent with the stated purpose of this website.